Neurological Institute Outcomes
Surgical Quality Improvement
Neurosurgery Outcomes
January 1, 2024 – December 31, 2024
The American College of Surgeons National Surgical Quality Improvement Program (ACS NSQIP®) objectively measures and reports risk-adjusted surgical outcomes based on a defined sampling and abstraction methodology. These outcomes data reflect Cleveland Clinic’s overall neurosurgery ACS NSQIP performance benchmarked against 309 participating sites.
| Neurosurgery (309 Sites) | N | Observed | Expected |
|---|---|---|---|
| 30 Day Mortality | 316 | 1.90% | 1.87% |
| 30 Day Morbidity | 316 | 12.03% | 9.05% |
| Cardiac | 316 | 0.00% | 0.42% |
| Pneumonia | 316 | 3.16% | 2.04% |
| Unplanned Intubation | 316 | 3.48% | 1.65% |
| Ventilator > 48 Hours | 314 | 3.82% | 1.37% |
| Deep Vein Thrombosis (DVT) / Pulmonary Embolus | 316 | 3.16% | 2.93% |
| Renal Failure | 316 | 0.95% | 0.56% |
| Urinary Tract Infection (UTI) | 315 | 2.22% | 1.45% |
| Surgical Site Infection (SSI) | 316 | 2.22% | 2.12% |
| Sepsis | 316 | 1.27% | 1.33% |
| C.diff Colitis | 316 | 1.58% | 0.26% |
| Unplanned Reoperation | 316 | 3.80% | 4.43% |
| Unplanned Readmission | 316 | 9.49% | 9.85% |
American College of Surgeons National Surgical Quality Improvement Program, 2025.
ACS NSQIP® Semiannual Report July, 2025, Chicago: American College of Surgeons.
ᵃIdentified as a statistical outlier (higher than expected) by the ACS NSQIP hierarchical model.
